Intramuscular Temperature on the Echo-textural Characteristics

February 6, 2024 updated by: SERGIO MONTERO NAVARRO, Cardenal Herrera University

Influence of Intramuscular Temperature on the Textural Characteristics of the B-mode Ultrasound Image.

Echointensity and echotexture have been used as a physiological marker for changes in skeletal muscle quality and structure caused by physical training, low activity, ageing and some neuromuscular disorders. However, there are some influencing factors on muscle echo-intensity and echotexture, such as temperature, which may not be taken into account when performing an ultrasound assessment and may alter the results.

This study aims to investigate the effects of muscle temperature on echointensity and other 2nd order echotextures variables such as homogeneity, contrast, correlation and entropy of muscle tissue, in order to gain a better understanding of this correlation and minimise its influence, which would allow greater precision in the use of muscle ultrasound as a diagnostic tool.

The methodology of this study includes firstly the acquisition of ultrasound images of the vastus lateralis muscle. This acquisition will be performed during the continuous recording of muscle temperature, carried out during a passive cooling process after 20 min of heating using microwave equipment. In addition, to standardise the results, a correction factor will be calculated to compensate for the influence of subcutaneous adipose tissue thickness on echogenicity and echotexture.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Alicante
      • Elche, Alicante, Spain, 03203
        • Recruiting
        • Sergio Montero Navarro
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Acceptance of participation in the study.
  • Healthy subjects.
  • Subjects between the ages of 18 and 65.

Exclusion Criteria:

  • Have known neurological, cardiovascular, metabolic or orthopedic conditions that prevent them from participating in the study.
  • Present metal implants in the heating area.
  • Wear a pacemaker.
  • Perform physical activity during the 48 hours prior to data collection.
  • Contraindications of dry needling such as: Belonephobia, history of abnormal reaction to the puncture or injection, anticoagulant treatment or thrombocytopenia, lymphedema over the area of intervention, severely compromised immune system, vascular diseases, diabetes mellitus, pregnancy, epilepsy, allergy to metals or that the intervention area has wounds, scars, tattoos, or stains.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Muscle temperature
Heating the vastus lateralis of the right quadriceps using microwaves
Passive heating of the vastus lateralis of the right quadriceps will be performed using a microwave device. The device will be set at a power of 150 W and a distance of 10-15 cm from the skin surface for 20 minutes with the purpose of increasing local muscle temperature to 40 ºC.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscle echointensity (0-255 a.u.).
Time Frame: During intervention
Muscle echointensity is calculated by the mean gray level value of the muscle Range of Interest (ROI). (0-255 a.u.)
During intervention
Muscle echovariance (0-255 a.u.).
Time Frame: During intervention
The echovariance is determined by the relationship between the standard deviation and the average pixel intensity obtained from the histogram of the muscle ROI. (0-255 a.u.)
During intervention
Muscle energy or second angular momentum.
Time Frame: During intervention
It is a second order parameter (GLCM) that measures textural uniformity of the muscle ROI
During intervention
Muscle homogeneity.
Time Frame: During intervention
It is a second-order parameter (GLCM) that measures the uniformity of the muscle ROI composition.
During intervention
Contrast.
Time Frame: During intervention
It is a second-order parameter (GLCM) that measures local variations in gray levels of the muscle ROI.
During intervention
Textural Correlation.
Time Frame: During intervention
It is a second-order parameter (GLCM) that expresses linear gray-level dependencies of the muscle ROI.
During intervention
Entropy.
Time Frame: During intervention
It is a second-order parameter (GLCM) to measure muscle ROI disorder.
During intervention
Echointensity correction factor for adipose thickness
Time Frame: Pre-intervention
The measurement of subcutaneous adipose thickness will be carried out through the average of the distance from the skin to the aponeurosis coinciding with the superficial interface of the muscle and with different pressures of the probe on the skin. This measure will be used to develop a correction factor that allows compensating the influence of this variable on echogenicity and echotexture, standardizing the results.
Pre-intervention
Muscle temperature (ºC).
Time Frame: Pre-intervention and during intervention
Measurement of intramuscular temperature of the right vastus lateralis of the quadriceps (ºC)
Pre-intervention and during intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Age (years)
Time Frame: Pre-intervention
Subject's age (years)
Pre-intervention
Sex (female or male)
Time Frame: Pre-intervention
Subject's sex (female or male)
Pre-intervention
Dominance
Time Frame: Pre-intervention
Dominant leg (right-left)
Pre-intervention
Body mass index
Time Frame: Pre-intervention
It is a measure of body fat based on height and weight that applies to adult men and women
Pre-intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 30, 2023

Primary Completion (Actual)

December 1, 2023

Study Completion (Estimated)

June 1, 2024

Study Registration Dates

First Submitted

November 17, 2023

First Submitted That Met QC Criteria

November 17, 2023

First Posted (Actual)

November 24, 2023

Study Record Updates

Last Update Posted (Estimated)

February 7, 2024

Last Update Submitted That Met QC Criteria

February 6, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • CEEI23_453

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Access to identified personal information will be restricted to the principal investigator of the study/collaborators, the Research Ethics Committee and authorized personnel, when necessary to verify the data and procedures of the study, but always maintaining their confidentiality in accordance to current legislation.

The personal data of the participants, obtained during their participation in the project, will be kept for the time necessary for the development of this research, which is estimated to be 6 months, and will subsequently be destroyed, and cannot be kept without having previously been anonymized.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Subjects

Clinical Trials on Muscle warm-up

3
Subscribe